A 7-year-old girl from a rural village in Rajasthan presents with recurrent eye discharge and mild photophobia for the past 6 months. On examination, she has mild conjunctival injection, scanty mucoid discharge, and fine linear scars on the upper tarsal conjunctiva. Giemsa staining of conjunctival scraping reveals intracytoplasmic inclusion bodies. What is the most likely diagnosis?

Explanation

## Diagnosis: Trachoma — Active Infection ### Clinical Presentation This child presents with classic features of trachoma caused by **Chlamydia trachomatis** (serovars A, B, Ba, C): - **Epidemiology:** Rural Rajasthan — an endemic region with poor sanitation and hygiene - **Age:** School-age child (peak transmission age group) - **Duration:** Chronic, recurrent course (6 months) - **Symptoms:** Mild discharge, photophobia - **Signs:** Conjunctival injection, mucoid discharge, **fine linear scars on upper tarsal conjunctiva** ### Diagnostic Confirmation **Giemsa staining showing intracytoplasmic inclusion bodies** confirms *Chlamydia trachomatis* infection. These basophilic inclusions (Halberstaedter–Prowazek bodies) are found within conjunctival epithelial cells and are pathognomonic for chlamydial infection. ### WHO Classification of Trachoma (Thylefors Grading) | Stage | Clinical Features | |-------|------------------| | **TF** | ≥5 follicles on upper tarsal conjunctiva (active infection) | | **TI** | Papillary hypertrophy, diffuse intense inflammation | | **TS** | Linear/Arlt's scars on upper tarsal conjunctiva (fibrosis) | | **TT** | Trichiasis — inturned eyelashes | | **CO** | Corneal opacity from repeated scarring | **Important staging note:** The presence of **fine linear scars on the upper tarsal conjunctiva** technically corresponds to the **TS (Trachomatous Scarring)** stage in the WHO grading system, indicating prior or ongoing chronic infection. In clinical practice, active infection (TF/TI) and early scarring (TS) frequently coexist in endemic settings, especially in children with recurrent disease. The Giemsa-confirmed intracytoplasmic inclusions confirm ongoing active *Chlamydia trachomatis* infection superimposed on early scarring — a mixed TF+TS presentation. The overall diagnosis remains **trachoma**, which is the only option consistent with all findings. ### Why Other Options Are Wrong - **Adenoviral keratoconjunctivitis:** Acute onset, follicles predominantly on *bulbar* (not tarsal) conjunctiva, preauricular lymphadenopathy, NO intracytoplasmic inclusions on Giemsa - **Allergic conjunctivitis:** Bilateral itching, papillae (not follicles), eosinophils on smear, no inclusion bodies - **Staphylococcal bacterial conjunctivitis:** Purulent discharge, gram-positive cocci on smear, no intracytoplasmic inclusions, no tarsal scarring ### Pathophysiology 1. *C. trachomatis* infects columnar conjunctival epithelium → intracytoplasmic inclusions 2. Chronic inflammation → follicle formation on upper tarsal conjunctiva 3. Repeated infection → progressive fibrosis → **Arlt's line** (horizontal scar on upper tarsal conjunctiva) 4. Advanced disease → trichiasis, entropion, corneal pannus → blindness **High-Yield:** Trachoma is the **leading infectious cause of preventable blindness worldwide** (WHO). The **Arlt's line** (linear scar on upper tarsal conjunctiva) is pathognomonic for trachomatous scarring. ### Treatment (SAFE Strategy — WHO) - **S**urgery: For trichiasis/entropion - **A**ntibiotics: Azithromycin 20 mg/kg single dose (community-wide); topical tetracycline 1% ointment BD × 6 weeks - **F**acial cleanliness - **E**nvironmental improvement **Clinical Pearl:** Per *Khurana's Comprehensive Ophthalmology* and *Park's Textbook of Preventive and Social Medicine*, the combination of tarsal conjunctival scarring + Giemsa-confirmed intracytoplasmic inclusions in a child from an endemic region is diagnostic of trachoma, regardless of the precise WHO stage.